Critical Care Reviews Profile picture
Apr 4, 2023 28 tweets 14 min read Read on X
➡️ Death has always fascinated human civilisations
➡️ Not just the ending of a life, but either preparation for the afterlife or attempts to restore an existing life

A 🧵

1/28 Image
➡️ Ancient Egyptians preserved corpses via mummification for an afterlife
➡️ They removed internal organs, used embalming fluids, linen bandages, & intricate coffins
➡️ The wealthy had pyramids
➡️ Relatives, staff & pets were buried alive for the journey to the afterlife

2/28 Image
➡️ In Greek Mythology, the River Styx separated the worlds of the living & dead
➡️ Charon, the Ferryman, required payment from the deceased for passage
➡️ The dead were buried with a coin
➡️ Those unable to pay were left to wander the river bank for 100 years

3/28 Image
➡️ Mary Shelley's classic novel Frankenstein explored the theme of overcoming death
➡️ Dr Frankenstein created a living being by assembling body parts from the deceased
➡️ As a child, Shelly was fascinated by stories of electrical currents stimulating movement in corpses

4/28 Image
➡️ The modern management of cardiac arrest mirrors these themes
➡️ Resuscitation enables life to be snatched from the jaws of death
➡️ Post arrest management potentially allows the person to be saved
➡️ Many interventions have been tested

5/28 Image
➡️ Based on incredible stories of survival after prolonged immersion in freezing water or snow, hypothermia has been extensively investigated post arrest
➡️ Led by the TTM trials, numerous high quality studies have failed to convincingly demonstrate benefit from cooling

6/28 Image
➡️ Barbituates were developed by Adolf von Baeyer in 1864
➡️ They were introduced into clinical practice in 1904 for treatment of sleep disorders, seizures, and psychoses
➡️ The name barbituates may have come in honour of von Baeyer's friend Barbara

7/28 Image
➡️ In 1986, thiopental was tested post cardiac arrest
➡️ 262 comatose survivors were randomised to 1 dose of 30 mg/kg or placebo
➡️ 1 year outcomes were similar
🔴 survival - 77 v 80%
🔴 neuro recovery - good 20 v 15% | poor 2 v 5%
➡️ Neither did it work taken pre-arrest

8/28 Image
➡️ Xenon was discovered in 1898 by British chemists William Ramsay & Morris Travers
➡️ It was first used clinically as an anaesthetic agent in 1951 by American Stuart Cullen
➡️ In animal models, xenon has neuroprotective effects post cardiac arrest

9/28 Image
➡️ Xenon was tested in 2016 in 110 comatose patients after OHCA
➡️ Patients were randomised to inhaled xenon or not
➡️ Both groups were treated at 33C
➡️ Xenon resulted in
🔴 less white matter damage
🔴 similar functional outcomes
🔴 similar mortality at 6/12 (27% vs 34%)

10/28 Image
➡️ Exenatide is a glucagon-like peptide-1 analog used for the management of diabetes mellitus
➡️ It was first isolated by John Eng in 1992
➡️ Exenatide has various neuroprotective effects, including reducing cerebral infarction volume

11/28 Image
➡️ It was tested in an RCT in 2016
➡️ 120 comatose patients after out-of-hospital cardiac arrest were randomised to exenatide or placebo
➡️ Brain injury, as measured by neuron specific enolase levels, were similar between groups
➡️ Functional outcomes were also similar

12/28 Image
➡️ Calcium channel blockers may limit the ischaemia-induced entry of calcium into cells
➡️ Nimodipine is widely used in aneurysmal subarachnoid haemorrhage for the prevention of delayed cerebral ischaemia
➡️ However, the exact mechanism of action in aSAH remains unclear

13/28 Image
➡️ in 1990, 155 patients after out-of-hospital VF cardiac arrest were randomised to IV nimodipine or placebo
🔴 One year survival was similar (40% vs 36%)
🔴 Nimodipine resulted in less recurrent VF

14/28
➡️ Lidoflazine is also a calcium channel blocker
➡️ A trial in 1991 randomised 520 comatose cardiac arrest survivors to lidoflazine or placebo
➡️ 6 month outcomes were similar
🔴 survival - 82 v 83%
🔴 neuro recovery - good 15 v 13% | poor 1.2 v 1.9%

15/28 Image
➡️ A hormone was first postulated as an erythropoiesis stimulating agent in 1905 by Paul Carnot
➡️ Erythropoietin has a range of effects across different tissues
➡️ The brain has Epo receptor–expressing cells & erythropoietin may have potential neuroprotective effects

16/28 Image
➡️A French trial randomised 476 patients post OHCA to IV erythropoietin or not
➡️5 IV doses of 40K units were given
🔴At day 60, the % with CPC scores of 1 were similar in each group - 32% v 32%
🔴The epo group suffered more adverse events, including thromboses (12 v 6%)

17/28 Image
➡️ Although adequate cerebral perfusion is necessary for neuronal activity, the optimal blood pressure post cardiac arrest is unknown
➡️ Targeting too high a pressure risks further myocardial damage
➡️ Too low a pressure risks cerebral ischaemia

18/28 Image
➡️ In 2022, the BOX trial compared mean arterial pressure targets of 77 with 63 mmHg in 789 pts post OHCA
➡️ Outcomes were similar between groups
🔴 Composite primary outcome of death or poor neuro recovery (34% vs 32%)
🔴 Day 90 mortality 31% v 29%

19/28 Image
➡️ Hyperoxia has been associated with worse outcomes across a range of conditions, including cardiac arrest
➡️ By targeting a lower oxygen level, hyperoxia may be avoided
➡️ However, hypoxia's not great either for an injured brain....

20/28 Image
➡️2 large trials were published in 2022 investigating oxygenation post cardiac arrest
➡️The Australian EXACT trial compared SpO2s of 90-94% with 98-100% in 428 pts
➡️The Danish BOX trial compared 9-10 with 13-14 kPa in 789 pts
🔴Group outcomes were similar in both trials

21/28 Image
➡️ Carbon dioxide has many physiological effects relevant to cardiac arrest
➡️ It is a major determinant of cerebral blood flow, potentially increasing cerebral perfusion without use of injurious catecholamines
➡️ It is also anticonvulsant, anti-inflammatory & antioxidant

22/28 Image
➡️The Finnish COMACARE trial examined low (4.5–4.7) & high (5.8–6.0 kPa) PaCO2 in 120 patients post OHCA
🔴Median serum NSE levels were similar at 48 hours - 18.8 v 22.5 μg/l
🔴Notably, the median cerebral oxygen saturation was higher in the high-normal PaCO2 group

23/28 Image
➡️ The Australian pilot CCC trial also compared low (4.7-6.0) & high (6.7-7.3 kPA) PaCO2 levels in 86 patients post cardiac arrest
➡️ The trial demonstrated the intervention was feasible & safe

24/28 Image
➡️ With other interventions proving disappointing, the role for targeted therapeutic mild hypercapnia remains open
➡️ Any effective therapy would be significant
🔴 > 356,000 OHCAs in the USA pa
🔴 <50% who reach hospital survive
🔴 7% survive with good neuro recovery

25/28 Image
➡️ Join us in @TitanicBelfast to hear the results of the international @TAMEtrial at #CCR23
➡️ @Eastwoodgm will present the results with Alistair Nichol

➡️ Will we soon be providing targeted therapeutic mild hypercapnia?

🚩Registration is open criticalcarereviews.com/meetings/ccr23

26/28 Image
@TitanicBelfast @TAMEtrial @Eastwoodgm ➡️ #CCR23 is supported by

🔴 @VisitBelfast
🔴 @belfastcc
🔴 @NITouristBoard
🔴 @BelfastTrust

See you in Belfast in June

27/28 Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Critical Care Reviews

Critical Care Reviews Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @CritCareReviews

May 4, 2023
➡️ Antimicrobial therapy has been used for millennia
➡️ Treating severe infections can be lifesaving
➡️ However, the widespread use of antimicrobials also has downsides

A 🧵

1/16 Image
➡️ Throughout history, honey, herbs & metals were often used
➡️ One of the earliest known antimicrobial therapies was the topical use of mouldy bread
➡️ This intervention has been recorded in many ancient civilisations, including Egypt, China, Serbia, Greece & Rome

2/16 Image
➡️ Mercury was used for epidemic diseases since the 1300s & especially syphilis
➡️ However, the treatment could be worse than the disease, with mercury poisoning possible
➡️ Treatment could last years, leading to the saying “A night with Venus, a lifetime with mercury”"

3/16 Image
Read 16 tweets
Apr 20, 2023
➡️ Throughout history, the most mystical substance of all has been blood
➡️ It has been coveted and desired
➡️ Fought for and defended
➡️ Stolen, yet freely given

A 🧵

1/16 Image
➡️ Blood has always been a symbol of power
➡️ In Greek mythology, ichor, the blood of the Gods, was a golden fluid
➡️ It was immortal, pure, & untainted by human weaknesses
➡️ The Gods derived their divine powers & longevity from it

2/16 Image
➡️ Blood has been revered for its restorative properties
➡️ Elizabeth Báthory, a 16th-century Hungarian noblewoman, allegedly killed hundreds of young girls & women
➡️ She bathed in their blood to maintain her youth & beauty

3/16 Image
Read 16 tweets
Apr 6, 2023
➡️ There are ~ 5.8 million trauma deaths per year globally
➡️ Trauma is the largest cause of death below the age of 50
➡️ One-third of severely injured trauma patients are coagulopathic at hospital arrival
➡️ Fibrinogen is often used, but is it effective?

a short 🧵

1/10 Image
➡️ Trauma-induced coagulopathy is due to inflammation & shock
➡️ It is worsened by hypothermia, acidosis, and hemodilution
➡️ Coagulopathy due to hemorrhage is strongly associated with mortality
➡️ 1/3 of early trauma deaths are due to uncontrolled haemorrhage

2/10 Image
➡️ Fibrinogen is depleted early during major bleeding
➡️ It can be replaced with fresh frozen plasma, cryoprecipitate or fibrinogen concentrate
➡️ Cryoprecipitate includes fibrinogen, factor VIII coagulant, von Willebrand factor, fibronectin & factor XIII

3/10 Image
Read 10 tweets
Mar 23, 2023
🚩 Tranexamic Acid - it's complicated....

➡️It's widely used for treatment & prevention of haemorrhage
➡️It's in the WHO's List of Essential Medicines & recommended in the European Traumatic Haemorrhage guideline (2023)
➡️But is it as efficacious as we think?

🧵 1/17
🚩 History

➡️Drs. Utako & Shosuke Okamoto invented TXA in 1962
➡️They identified that the amino acid lysine inhibited the degradation of plasmin, a profibrinolytic enzyme
➡️Lysine was modified to first produce Epsilon- Amino-Caproic Acid and later TXA, x 27 more potent

2/17
🚩 Pharmacology

➡️TXA is a molecular analog of lysine
➡️It inhibits fibrinolysis by preventing the binding of plasminogen to fibrin
➡️This inhibits plasmin formation & displaces plasminogen from the fibrin surface
➡️It also has effects on the immune system & inflammation

3/17
Read 18 tweets
Mar 21, 2023
The Annual Update in Intensive Care and Emergency Medicine 2023 articles have been released to coincide with the Brussels Meeting @ISICEM

10 great papers to enjoy

A thread.....

CCR Journal Watch
criticalcarereviews.com/latest-evidenc…
@ISICEM 1/10

Pelaia. The Role of Transcriptomics in Redefining Critical Illness. Crit Care 2023;27:89

CCR Journal Watch
criticalcarereviews.com/latest-evidenc…
@ISICEM 2/10

Neyton. Metagenomic Sequencing in the ICU for Precision Diagnosis of Critical Infectious Illnesses. Crit Care 2023;27:90

CCR Journal Watch
criticalcarereviews.com/latest-evidenc…
Read 11 tweets
Mar 20, 2023
1/13

➡️ REBOA is an exciting "new" therapy for non-compressible torso haemorrhage
➡️ It's used across the world, but without robust evidence
➡️ Does it work? Is it beneficial?
➡️ A thread...
2/13

🚩 Uncontrollable haemorrhage accounts for
 ➡️ > 80% of combat deaths
  ➡️ ~ 40% of civilian trauma-related deaths
🚩 Many have been determined to be preventable deaths
🚩 ~ 67% of fatal bleeding occurs in the torso region
3/13

Emergency thoracotomy (ET) has a long history in resuscitation

🚩 1880 - Paul Niehans first documented ET in human cardiac arrest
🚩 1901 - Kristian Ingelsrud performed the first successful resuscitation
🚩 1953 - Stephenson had 28% survival in 1200 cardiac arrests
Read 13 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(